Literature DB >> 31852745

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.

Thomas Radtke1,2, Sarah Crook1, Georgios Kaltsakas3,4, Zafeiris Louvaris5, Danilo Berton6, Don S Urquhart7, Asterios Kampouras8, Roberto A Rabinovich9,10, Samuel Verges11, Dimitris Kontopidis12, Jeanette Boyd13, Thomy Tonia14, Daniel Langer5,15, Jana De Brandt16, Yvonne M J Goërtz17, Chris Burtin16, Martijn A Spruit16,17,18, Dionne C W Braeken17, Sauwaluk Dacha5,15,19, Frits M E Franssen17,18, Pierantonio Laveneziana20,21, Ernst Eber22, Thierry Troosters23,24, J Alberto Neder25, Milo A Puhan1, Richard Casaburi26, Ioannis Vogiatzis4,27,28, Helge Hebestreit29,28.   

Abstract

The objective of this document was to standardise published cardiopulmonary exercise testing (CPET) protocols for improved interpretation in clinical settings and multicentre research projects. This document: 1) summarises the protocols and procedures used in published studies focusing on incremental CPET in chronic lung conditions; 2) presents standard incremental protocols for CPET on a stationary cycle ergometer and a treadmill; and 3) provides patients' perspectives on CPET obtained through an online survey supported by the European Lung Foundation. We systematically reviewed published studies obtained from EMBASE, Medline, Scopus, Web of Science and the Cochrane Library from inception to January 2017. Of 7914 identified studies, 595 studies with 26 523 subjects were included. The literature supports a test protocol with a resting phase lasting at least 3 min, a 3-min unloaded phase, and an 8- to 12-min incremental phase with work rate increased linearly at least every minute, followed by a recovery phase of at least 2-3 min. Patients responding to the survey (n=295) perceived CPET as highly beneficial for their diagnostic assessment and informed the Task Force consensus. Future research should focus on the individualised estimation of optimal work rate increments across different lung diseases, and the collection of robust normative data.
Copyright ©ERS 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31852745     DOI: 10.1183/16000617.0101-2018

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  31 in total

1.  Differences in Pulmonary and Extra-Pulmonary Traits between Women and Men with Chronic Obstructive Pulmonary Disease.

Authors:  Sara Souto-Miranda; Alex J van 't Hul; Anouk W Vaes; Jeanine C Antons; Remco S Djamin; Daisy J A Janssen; Frits M E Franssen; Alda Marques; Martijn A Spruit
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

2.  Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls.

Authors:  Rhys I Beaudry; Andrew R Brotto; Rhea A Varughese; Stephanie de Waal; Desi P Fuhr; Ronald W Damant; Giovanni Ferrara; Grace Y Lam; Maeve P Smith; Michael K Stickland
Journal:  Front Physiol       Date:  2022-07-06       Impact factor: 4.755

3.  The Effect of Dysglycaemia on Changes in Pulmonary and Aerobic Function in Cystic Fibrosis.

Authors:  Owen W Tomlinson; Anna L E Stoate; Lee Dobson; Craig A Williams
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

4.  Exercise Tolerance in Patients With Idiopathic Pulmonary Fibrosis, Effect of Supplemental Oxy-Gen.

Authors:  J Chlumský; L Stehlík; M Šterclová; J Smetanová; O Zindr
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

5.  Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD.

Authors:  Ellen Tufvesson; Finn Radner; Georgia Papapostolou; Linnea Jarenbäck; Saga Jönsson; Ulf Nihlén; Jaro Ankerst; Alf Tunsäter; Stefan Peterson; Leif Bjermer; Göran Eriksson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-19

6.  Pulmonology approach in the investigation of chronic unexplained dyspnea.

Authors:  Danilo Cortozi Berton; Nathalia Branco Schweitzer Mendes; Pedro Olivo-Neto; Igor Gorski Benedetto; Marcelo Basso Gazzana
Journal:  J Bras Pneumol       Date:  2021-02-08       Impact factor: 2.624

7.  Normative Cardiopulmonary Exercise Test Responses at the Ventilatory Threshold in Canadian Adults 40 to 80 Years of Age.

Authors:  Hayley Lewthwaite; Omar Elsewify; Frank Niro; Jean Bourbeau; Jordan A Guenette; François Maltais; Darcy D Marciniuk; Denis E O'Donnell; Benjamin M Smith; Michael K Stickland; Wan C Tan; Dennis Jensen
Journal:  Chest       Date:  2020-11-18       Impact factor: 9.410

8.  Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.

Authors:  Vasiliki-Kalliopi Bournia; Anastasios Kallianos; Stylianos Panopoulos; Elias Gialafos; Lemonia Velentza; Panayiotis G Vlachoyiannopoulos; Petros P Sfikakis; Georgia Trakada
Journal:  Rheumatol Int       Date:  2021-06-29       Impact factor: 2.631

9.  Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation.

Authors:  Ingunn Skjørten; Odd Andre Wathne Ankerstjerne; Divna Trebinjac; Eivind Brønstad; Øystein Rasch-Halvorsen; Gunnar Einvik; Tøri Vigeland Lerum; Knut Stavem; Anne Edvardsen; Charlotte Björk Ingul
Journal:  Eur Respir J       Date:  2021-08-26       Impact factor: 16.671

10.  Exercise Intolerance in Cystic Fibrosis: Importance of Skeletal Muscle.

Authors:  Paula Rodriguez-Miguelez; Nichole Seigler; Haruki Ishii; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Med Sci Sports Exerc       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.